PT-141 & medicine safety
- A clinician must confirm the indication and exclude other causes
- It is contraindicated with uncontrolled hypertension or known cardiovascular disease
- It can temporarily increase blood pressure and reduce heart rate
- Nausea is common and can be severe
- Persistent focal darkening of skin can occur
Prescription treatment must match the approved indication, risks and individual assessment.
PT-141 & medicine safety
Find the approved indication
Check who the medicine is actually approved for. A claim aimed at a group outside the approved indication is off-label marketing, whatever it is called.
Check the formulation
Compare the route and form being offered with the approved product. A nasal spray, troche or compounded vial is not the same product as an approved injection, and its absorption and evidence differ.
Identify the prescriber
Establish which licensed clinician is taking responsibility, and whether an individual assessment took place before supply.
Trace the source
Look for current prescribing information from a regulator or official label database rather than a clinic page, a forum, a reseller or a social post.
PT-141 & medicine safety
- It does not supply, sell, prescribe or arrange this or any other prescription medicine
- It does not recommend the medicine to any reader, including anyone within the approved indication
- It does not provide a dose, a protocol, a schedule or an administration instruction
- It does not assess whether the medicine would be appropriate for you — only a licensed clinician with your history can do that